English | Español
Jamie Barrand | Dec 10, 2015

Boehringer Ingelheim researchers test nintedanib on patients with severe lung disease
Jamie Barrand | Dec 10, 2015

FDA grants priority review to Pfizer cancer treatment
Jamie Barrand | Dec 8, 2015

Pfizer awards more than $4 million in grants for breast cancer research programs
Jamie Barrand | Dec 8, 2015

FDA approves Pfizer's new chewable ADHD treatment
Jamie Barrand | Dec 8, 2015

Breakthrough could spur diabetes therapy development
Jamie Barrand | Dec 8, 2015

Treatment for rare Wolman disease wins FDA approval
Jamie Barrand | Dec 7, 2015

Slavitt speaks at HHS pharmaceutical forum
Jamie Barrand | Dec 7, 2015

Allergan partners with Rugen Therapeutics to develop autism, OCD therapies

Trending
Patient Daily | Sep 3, 2025

Top healthcare marketing experts to present at AOCOO-HNS 2025 virtual mid-year symposium, led by Greg Caesar of Medfluence Advisors
+ Pharmaceuticals
Patient Daily | Sep 4, 2025

PhRMA CEO on 340B abuse: ‘Big hospitals are abusing the 340B program to markup medicine prices’
+ Pharmaceuticals
Patient Daily | Aug 29, 2025

Deputy VP of Public Affairs of PhRMA on 340B: ‘Over 80% of all rural hospital beds were actually in urban hospitals’
+ Pharmaceuticals
Patient Daily | Sep 2, 2025

Fmr. Gov. Dean on 340B: ‘There's no actual requirement for hospitals to pass along the savings’